PC
Polar Capital Portfolio holdings
AUM
$13.5B
This Quarter Return
+6.47%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$5.29B
AUM Growth
+$5.29B
(+3.2%)
Cap. Flow
+$85.2M
Cap. Flow
% of AUM
1.61%
Top 10 Holdings %
Top 10 Hldgs %
23.19%
Holding
321
New
66
Increased
92
Reduced
85
Closed
35
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
$83.7M |
| 2 |
Pfizer
PFE
|
$60.3M |
| 3 |
HCA Healthcare
HCA
|
$36.6M |
| 4 |
Johnson & Johnson
JNJ
|
$34.5M |
| 5 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$30.3M |
Top Sells
| 1 |
RTX Corp
RTX
|
$39.8M |
| 2 |
Microsoft
MSFT
|
$38M |
| 3 |
Abbott
ABT
|
$32.1M |
| 4 |
Perrigo
PRGO
|
$29.5M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$29.2M |
Sector Composition
| 1 | Technology | 26.44% |
| 2 | Healthcare | 24.73% |
| 3 | Financials | 20.02% |
| 4 | Communication Services | 11.49% |
| 5 | Consumer Discretionary | 5.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVDQ
201
DELISTED
Novadaq Technologies Inc.
NVDQ
| $2.11M | 0.04% |
130,000
| – | – |
|
202
Omega Healthcare
OHI
$12.5B
| $2.03M | 0.04% |
50,000
| – | – |
|
203
Gilead Sciences
GILD
$140B
| $2M | 0.04% |
20,382
+9,222
| +83% | +$905K |
|
|
204
Perrigo
PRGO
$3.21B
| $1.99M | 0.04% |
12,000
-178,000
| -94% | -$29.5M |
|
205
Vertex Pharmaceuticals
VRTX
$102B
| $1.96M | 0.04% |
16,589
+12,260
| +283% | +$1.45M |
|
|
MDVN
206
DELISTED
MEDIVATION, INC.
MDVN
| $1.95M | 0.04% |
15,124
+8,207
| +119% | +$1.06M |
|
207
Welltower
WELL
$112B
| $1.94M | 0.04% |
25,000
| – | – |
|
|
ALXN
208
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.92M | 0.04% |
11,054
+5,664
| +105% | +$982K |
|
|
TWO
209
Two Harbors Investment
TWO
$1.05B
| $1.91M | 0.04% |
180,000
| – | – |
|
210
WisdomTree
WT
$1.99B
| $1.78M | 0.03% |
82,700
-14,351
| -15% | -$308K |
|
|
DHC
211
Diversified Healthcare Trust
DHC
$903M
| $1.77M | 0.03% |
80,000
| – | – |
|
212
National Health Investors
NHI
$3.68B
| $1.77M | 0.03% |
25,000
| – | – |
|
213
Baxter International
BAX
$12.1B
| $1.71M | 0.03% |
25,000
+10,000
| +67% | +$685K |
|
214
Telus
TU
$25.1B
| $1.69M | 0.03% |
+45,000
| New | +$1.69M |
|
|
HR
215
DELISTED
Healthcare Realty Trust Incorporated
HR
| $1.67M | 0.03% |
60,000
| – | – |
|
|
AA.PRB
216
DELISTED
Alcoa Inc.
AA.PRB
| $1.66M | 0.03% |
+38,000
| New | +$1.66M |
|
217
Sabra Healthcare REIT
SBRA
$4.56B
| $1.66M | 0.03% |
50,000
| – | – |
|
218
Kinder Morgan
KMI
$59.4B
| $1.58M | 0.03% |
+37,500
| New | +$1.58M |
|
|
MTLS
219
Materialise
MTLS
$291M
| $1.55M | 0.03% |
+226,429
| New | +$1.55M |
|
|
HMSY
220
DELISTED
HMS Holdings Corp.
HMSY
| $1.51M | 0.03% |
97,798
-813,860
| -89% | -$12.6M |
|
221
Teradata
TDC
$1.96B
| $1.5M | 0.03% |
+33,919
| New | +$1.5M |
|
222
CVS Health
CVS
$93B
| $1.45M | 0.03% |
14,000
+5,000
| +56% | +$516K |
|
223
Supernus Pharmaceuticals
SUPN
$2.52B
| $1.35M | 0.03% |
111,673
+79,245
| +244% | +$958K |
|
224
Agilent Technologies
A
$35.5B
| $1.25M | 0.02% |
30,000
+15,000
| +100% | +$624K |
|
225
BioMarin Pharmaceuticals
BMRN
$11.3B
| $1.24M | 0.02% |
9,963
+2,088
| +27% | +$260K |
|